Dan M. Berger

4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile Inhibitors of Epidermal Growth Factor Receptor Kinase and Their Bioisosteric Relationship to the 4-Anilino-6,7-dialkoxyquinazoline Inhibitors

Allan Wissner, Dan M. Berger, Diane H. Boschelli et al. · Journal of Medicinal Chemistry · 2000 · 209 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment

Lori M. Miller, Scott C. Mayer, Dan M. Berger et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 42 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Non-hinge-binding pyrazolo[1,5-a]pyrimidines as potent B-Raf kinase inhibitors

Dan M. Berger, Nancy Torres, Minu Dutia et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 36 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Dramatic Effect of Solvent Hydrogen Bond Basicity on the Regiochemistry of S_NAr Reactions of Electron-Deficient Polyfluoroarenes

Xiaolun Wang, Edward J. Salaski, Dan M. Berger et al. · Organic Letters · 2009 · 32 citations

Natural Sciences, Chemistry, Catalysis +14

Novel pyrazolopyrimidines as highly potent B-Raf inhibitors

Martin J. Di Grandi, Dan M. Berger, Darrin W. Hopper et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 30 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9